Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

The start-up, which aims to raise tens of millions of US dollars in an angel funding round, hopes to compete globally, ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Discover Grok 4, the AI model redefining advanced reasoning and problem-solving. Explore its potential, challenges, and ...

Wayve was among the first unicorn AI startups in the UK, getting funding of over $1 billion for its self-driving artificial intelligence technology. The company is based in London and had its ...

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

The latest version of Google DeepMind and Isomorphic Labs’ AlphaFold model can predict the structure and relationships not only of proteins, but “all of life’s molecules”, according to its ...

It follows shortly after another Alphabet start-up, Isomorphic Labs, announced its first pharma partnerships with Eli Lilly and Novartis, collectively worth almost $3 billion and focused on the ...

Researchers are making ever more sophisticated mini organs in the lab — and now they can grow their own blood vessels. The ...

Elon Musk has launched xAI’s Grok 4—calling it the “world’s smartest AI” and claiming it can ace Ph.D.-level exams and ...